To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 9, 2023

Primary Completion Date

March 20, 2025

Study Completion Date

April 27, 2025

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

STSA-1002 Injection Placebo

Intravenous infusion

DRUG

STSA-1002 Injection

Intravenous infusion

Trial Locations (30)

100029

China-Japan Friendship Hospital, Beijing

101199

Beijing Luhe Hospital affiliated to Capital Medical University, Beijing

200001

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

210009

Zhongda Hospital affiliated to Southeast University, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

233099

The First Affiliated Hospital of Bengbu Medical University, Bengbu

250012

Qilu Hospital of Shandong University, Jinan

250013

Jinan Central Hospital, Jinan

255000

Zibo Municipal Hospital, Zibo

266071

Qingdao Municipal Hospital, Qingdao

310003

Hangzhou Red Cross Hospital, Hangzhou

325035

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330006

The First Affiliated Hospital of Nanchang University, Nanchang

400038

The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University, Chongqing

411100

Xiangtan Central Hospital, Xiangtan

430048

Wuhan Jinyintan Hospital, Wuhan

430062

Zhongnan Hospital of Wuhan University, Wuhan

450001

Huaihe Hospital of Henan University, Kaifeng

450003

Henan Provincial People's Hospital, Zhengzhou

453100

The First Affiliated Hospital of Xinxiang Medical College, Xingxiang

471099

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

475000

Kaifeng Central Hospital, Kaifeng

518036

Peking University Shenzhen Hospital, Shenzhen

530016

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

610072

Sichuan Provincial People's Hospital, Chengdu

610599

The First Affiliated Hospital of Chengdu Medical College, Chengdu

611130

Chengdu Fifth People's Hospital, Chengdu

710061

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi’an

050011

The Second Hospital of Hebei Medical University City:Shijiazhuang, Shijiazhuang

030032

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
lead

Staidson (Beijing) Biopharmaceuticals Co., Ltd

INDUSTRY

NCT06038916 - To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter